|
Jul 24
|
Contract research firms' strong earnings signal stabilizing biotech, pharma spending
|
|
Jul 24
|
CVS or DHR: Which Is the Better Value Stock Right Now?
|
|
Jul 23
|
Here's Why Danaher (DHR) is a Strong Growth Stock
|
|
Jul 23
|
Thermo Fisher flags improving tariff situation, raises annual profit view
|
|
Jul 23
|
Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ...
|
|
Jul 22
|
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline
|
|
Jul 22
|
Steven Cohen's Strategic Moves: A Closer Look at Danaher Corp's Impact on His Portfolio
|
|
Jul 22
|
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
|
|
Jul 22
|
Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Jul 22
|
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as More Corporate Earnings Awaited
|
|
Jul 22
|
Stocks Down Pre-Bell Ahead of Key Earnings, Fed Chair Powell's Speech
|
|
Jul 22
|
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
|
|
Jul 22
|
Danaher shares slip despite Q2 beat, annual profit outlook hike
|
|
Jul 22
|
Danaher: Q2 Earnings Snapshot
|
|
Jul 22
|
Danaher’s (NYSE:DHR) Q2 Sales Top Estimates But Quarterly Revenue Guidance Slightly Misses Expectations
|
|
Jul 22
|
Danaher Announces Transition Plan for Chief Financial Officer
|
|
Jul 22
|
Danaher Reports Second Quarter 2025 Results
|
|
Jul 21
|
India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher
|
|
Jul 21
|
Alphabet and Tesla Earnings, Powell Speech and More: What to Watch This Week
|
|
Jul 21
|
Danaher (DHR) Reports Q2: Everything You Need To Know Ahead Of Earnings
|